ArticleInternational journal of clinical oncology2024

Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.

Shuhei Hara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.